Delve Health on Track to Transform Clinical Trials Worldwide
Traction Capital has invested in an on-going partnership with a local Minnesota MedTech company with experience in clinical studies around the world. Delve Health reduces clinical trial costs and accelerated drug development by bringing the trials to patient homes, enabling more accurate data collection, and processing from wearables, digital health apps and sensors. The Minneapolis venture capital firm looks forward to helping the company continue their expansion.
Delve Health’s end-to-end solution combines web, mobile, SMS and wearables to make clinical trials more accessible to a broader group of patients to increase patient diversity and engagement. Ultimately, Delve Health’s technology platform improves clinical trial outcomes for pharma and medical device companies.
“We are very excited about partnering with Traction Capital. Their investment will allow us to nearly double our staff, while updating and strengthening our platform—all of which will allow us to continue to effectively help patients around the world” says Wessam Sonbol, co-founder and CEO of Delve Health. Delve Health has already supported 100+ studies and 26 registries in a variety of therapeutic areas. Their clients include medical device, pharmaceutical, and biotech manufacturers; clinical research organizations (CROs); as well as specific therapeutic area organizations.
The founders, Wessam Sonbol and Tamer Swidan, each have over 20 years of experience in healthcare and technology industries—making them extremely qualified to enter the MedTech world. With big goals on the horizon, they are looking to hire for a variety of positions, including individuals with expertise in sales, marketing, operations, and software development. Follow Delve Health as well as Traction Capital’s LinkedIn pages for more details and up-to-date information.
As they begin putting their investment to use, they plan to grow their team, expand their marketing efforts, and continue to work on product enhancements.
Key advantages of Delve Health’s solution include:
- Access to a large, diverse patient pool
- Reduction in patient burden and increase in patient data
- Minimized patient dropouts
Traction Capital and Delve Health are delighted to partner in pursuit of this growth opportunity. With similar principles, Traction Capital looks forward to helping Delve Health enhance their values and achieve high growth. “The Traction Capital team is looking forward to working with Delve Health as they remain focused on growing their business and making clinical trials more accessible to a greater number of people. We believe the industry is ready to embrace Delve Health’s innovative solution to virtual and hybrid clinical trials (e.g., decentralized clinical trials (DCTs)), which is validated by their growing number of contracts with major clinics around the world. We are excited to work with Wessam and his team as we implement processes and leverage our experienced network to add value and grow the business,” says Shane Erickson, Founder and Managing Partner of Traction Capital.